Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia.

Juneja SC, Vonica A, Zeiss C, Lezon-Geyda K, Yatsula B, Sell DR, Monnier VM, Lin S, Ardito T, Eyre D, Reynolds D, Yao Z, Awad HA, Yu H, Wilson M, Honnons S, Boyce BF, Xing L, Zhang Y, Perkins AS.

Bone. 2014 Mar;60:148-61. doi: 10.1016/j.bone.2013.11.020. Epub 2013 Dec 4.

2.

Quantification of ascorbic acid and sodium ascorbate in powder blends for tableting and in vitamin C chewable tablets by NIR-chemometry.

Tomuţă I, Dudaş D, Vonica AL, Leucuţa SE.

Acta Pharm. 2013 Sep;63(3):373-84. doi: 10.2478/acph-2013-0029.

PMID:
24152897
3.

Coco regulates dorsoventral specification of germ layers via inhibition of TGFβ signalling.

Bates TJ, Vonica A, Heasman J, Brivanlou AH, Bell E.

Development. 2013 Oct;140(20):4177-81. doi: 10.1242/dev.095521. Epub 2013 Sep 11.

4.

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.

Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG.

Cell. 2012 Aug 17;150(4):764-79. doi: 10.1016/j.cell.2012.06.035. Erratum in: Cell. 2012 Dec 7;151(6):1386-8.

5.

High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide powder blends for tabletting.

Porfire A, Rus L, Vonica AL, Tomuta I.

J Pharm Biomed Anal. 2012 Nov;70:301-9. doi: 10.1016/j.jpba.2012.07.026. Epub 2012 Jul 31.

PMID:
22884785
6.

Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4.

Warmflash A, Zhang Q, Sorre B, Vonica A, Siggia ED, Brivanlou AH.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):E1947-56. doi: 10.1073/pnas.1207607109. Epub 2012 Jun 11.

7.

High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting.

Tomuta I, Iovanov R, Vonica AL, Leucuta SE.

Sci Pharm. 2011 Oct-Dec;79(4):885-98. doi: 10.3797/scipharm.1108-07. Epub 2011 Oct 13.

8.

APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis.

Vonica A, Rosa A, Arduini BL, Brivanlou AH.

Dev Biol. 2011 Feb 1;350(1):13-23. doi: 10.1016/j.ydbio.2010.09.016. Epub 2010 Sep 27.

9.

APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex.

Shimomura Y, Agalliu D, Vonica A, Luria V, Wajid M, Baumer A, Belli S, Petukhova L, Schinzel A, Brivanlou AH, Barres BA, Christiano AM.

Nature. 2010 Apr 15;464(7291):1043-7. doi: 10.1038/nature08875.

10.

Scaling of BMP gradients in Xenopus embryos.

Francois P, Vonica A, Brivanlou AH, Siggia ED.

Nature. 2009 Sep 3;461(7260):E1; discussion E2.

PMID:
19736667
11.
12.

The left-right axis is regulated by the interplay of Coco, Xnr1 and derrière in Xenopus embryos.

Vonica A, Brivanlou AH.

Dev Biol. 2007 Mar 1;303(1):281-94. Epub 2006 Sep 28.

13.

An obligatory caravanserai stop on the silk road to neural induction: inhibition of BMP/GDF signaling.

Vonica A, Brivanlou AH.

Semin Cell Dev Biol. 2006 Feb;17(1):117-32. Epub 2006 Mar 3. Review.

PMID:
16516504
14.

FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.

Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE.

EMBO J. 2005 Jan 12;24(1):73-84. Epub 2004 Dec 9.

15.

Cell fate specification and competence by Coco, a maternal BMP, TGFbeta and Wnt inhibitor.

Bell E, Muñoz-Sanjuán I, Altmann CR, Vonica A, Brivanlou AH.

Development. 2003 Apr;130(7):1381-9.

16.
17.
18.

TCF is the nuclear effector of the beta-catenin signal that patterns the sea urchin animal-vegetal axis.

Vonica A, Weng W, Gumbiner BM, Venuti JM.

Dev Biol. 2000 Jan 15;217(2):230-43.

19.

Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.

Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ.

Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1121-30.

PMID:
7627705
20.
21.

The significance of low antithrombin III levels in cirrhosis.

Dumitraşcu DL, Radu D, Vonica A.

Rom J Intern Med. 1991 Jul-Dec;29(3-4):151-4.

PMID:
1784943
23.

Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours.

Lacombe ML, Sastre-Garau X, Lascu I, Vonica A, Wallet V, Thiery JP, Véron M.

Eur J Cancer. 1991;27(10):1302-7.

PMID:
1659843
24.

Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.

Vonica A, Văgăonescu T, Cristea A, Stăncioiu N.

Med Interne. 1990 Oct-Dec;28(4):311-7.

PMID:
2100876
25.
26.

Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.

Cucuianu M, Cristea A, Vonica A, Lascu I.

Med Interne. 1988 Jul-Sep;26(3):191-7.

PMID:
3187359

Supplemental Content

Loading ...
Support Center